Plain-English translation of NCT05940415 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โThis research study is testing a new approach for men who have warning signs of prostate cancer but appear to be at low risk. Instead of having an immediate biopsy โ a procedure where tissue is removed for testing โ this trial follows patients with regular blood tests (PSA testing) and MRI scans to see if this monitoring approach is safe and works well. The study uses a special computer tool called the USTC diagnostic model to help identify which patients are truly low-risk and can skip the biopsy.
Many men with early warning signs of prostate cancer end up having unnecessary biopsies that cause discomfort and anxiety but often show no cancer. This trial exists to see whether carefully selected low-risk patients can avoid this invasive procedure and instead be monitored safely with simpler, less invasive tests.
If you join this study, you will not have a biopsy right away. Instead, you'll come in every 3 months for a blood test to check your PSA level, and every 6 months for an MRI scan of your prostate. Every 3 months, your results will be put into the USTC computer model to reassess your cancer risk. If at any point your risk increases or your scans change, your doctor will recommend a biopsy. The study tracks how safe and effective this monitoring approach is for men like you.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
China